Novartis profit slips as key drug goes generic

Core net income fell 2% to $2.94b from $2.99b in the previous year’s quarter

Last updated:

Get Updates on Topics You Choose

By signing up, you agree to our Privacy Policy and Terms of Use.
Up Next